Enhancing diabetic wound healing with a pH/glucose dual-responsive hydrogel for ROS clearance and antibacterial activity.

Currently, the treatment of diabetic wounds in clinical practice is still unsatisfactory due to the risks of oxidative damage and bacterial infection during the healing process. An optimal wound dressing should exhibit robust capabilities in scavenging reactive oxygen species (ROS) and combatting bacterial growth. In this study, we utilized borax as a crosslinker and prepared a pH/glucose dual-responsive composite hydrogel based on poly(vinyl alcohol) (PVA), sodium alginate (SA), and tannic acid (TA). This hydrogel, loaded with cerium dioxide, serves as an effective ROS scavenger, promoting wound closure by reducing the level of ROS in the wound area. Additionally, the hydrogel can release the antibacterial drug ofloxacin in response to the low pH and high glucose microenvironment in infected wounds. Results from skin defect model in diabetic mice demonstrated this ROS-scavenging and antibacterial hydrogel can suppress inflammation and accelerate wound healing. In summary, our work provides a new perspective on a local and stimulus-responsive drug delivery strategy for treating diabetic wounds.

Sr-Stabilized IrMnO2 Solid Solution Nano-Electrocatalysts with Superior Activity and Excellent Durability for Oxygen Evolution Reaction in Acid Media.

The development of cost-effective catalysts for oxygen evolution reaction (OER) in acidic media is of paramount importance. This work reports that Sr-doped solid solution structural ultrafine IrMnO2 nanoparticles (NPs) (≈1.56 nm) on the carbon nanotubes (Sr-IrMnO2/CNTs) are efficient catalysts for the acidic OER. Even with the Ir use dosage 3.5 times lower than that of the commercial IrO2, the Sr-IrMnO2/CNTs only need an overpotential of 236.0 mV to drive 10.0 mA cm-2 and show outstanding stability for >400.0 h. Its Ir mass activity is 39.6 times higher than that of the IrO2 at 1.53 V. The solid solution and Sr-doping structure of Sr-IrMnO2 are the main origin of the high catalytic activity and excellent stability of the Sr-IrMnO2/CNTs. The density function theory calculations indicate that the solid solution structure can promote strong electronic coupling between Ir and Mn, lowering the energy barrier of the OER rate-determining step. The Sr-doping can enhance the stability of Ir against the chemical corrosion and demetallation. Water electrolyzers and proton exchange membrane water electrolyzers assembled with the Sr-IrMnO2/CNTs show superb performance and excellent durability in the acid media.

Achieving High Activity and Long-Term Stability towards Oxygen Evolution in Acid by Phase Coupling between CeO2-Ir.

The development of efficient and stable catalysts with high mass activity is crucial for acidic oxygen evolution reaction (OER). In this study, CeO2-Ir heterojunctions supported on carbon nanotubes (CeO2-Ir/CNTs) are synthesized using a solvothermal method based on the heterostructure strategy. CeO2-Ir/CNTs demonstrate remarkable effectiveness as catalysts for acidic OER, achieving 10.0 mA cm-2 at a low overpotential of only 262.9 mV and maintaining stability over 60.0 h. Notably, despite using an Ir dosage 15.3 times lower than that of c-IrO2, CeO2-Ir/CNTs exhibit a very high mass activity (2542.3 A gIr-1@1.53 V), which is 58.8 times higher than that of c-IrO2. When applied to acidic water electrolyzes, CeO2-Ir/CNTs display a prosperous potential for application as anodic catalysts. X-ray photoelectron spectrometer (XPS) analysis reveals that the chemical environment of Ir nanoparticles (NP) can be effectively modulated through coupling with CeO2. This modulation is believed to be the key factor contributing to the excellent OER catalytic activity and stability observed in CeO2-Ir/CNTs.

Dapper1 attenuates hepatic gluconeogenesis and lipogenesis by activating PI3K/Akt signaling.

Studies have shown that hepatic insulin resistance, a disorder of glucose and lipid metabolism, plays a vital role in type 2 diabetes (T2D). To clarify the function of Dapper1 in glucose and lipid metabolism in the liver, we investigated the relationships between Dapper1 and adenosine triphosphate (ATP)- and Ca2+-mediated activation of PI3K/Akt. We observed a reduction in hepatic Dapper1 in db/db (mice that are homozygous for a spontaneous diabetes mutation) and HFD-induced diabetic mice with T2D. Hepatic overexpression of Dapper1 improved hyperglycemia, insulin resistance, and fatty liver. It also increased Akt (pAkt) signaling and repressed both gluconeogenesis and lipogenesis. Conversely, Ad-shDapper1-induced knockdown of hepatic Dapper1 promoted gluconeogenesis and lipogenesis. Furthermore, Dapper1 activated PI3K p110α/Akt in an insulin-independent manner by inducing ATP production and secretion in vitro. Blockade of P2 ATP receptors, the downstream phospholipase C (PLC), or the inositol triphosphate receptor (IP3R all reduced the Dapper1-induced increase in cytosolic free calcium and Dapper1-mediated PI3K/Akt activation, as did removal of calcium in the medium. In conclusion, Dapper1 attenuates hepatic gluconeogenesis and lipogenesis in T2D.